Horizon Technology Finance Corp
Business
Horizon Technology Finance Corp is a specialty finance company that lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries. It offers secured debt investments (Venture Loans), senior term loans, warrants, equity positions and success-fee arrangements as its primary products and investment instruments. Its business is organized around venture lending activities managed by an external Advisor, including direct origination, underwriting, portfolio management and securitization strategies. It focuses on U.S.-based technology-related companies and sources transactions through venture capital and private equity firms, company management, advisers and public equity markets.
Summary from filing dated 2025-03-04
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Payment-in-kind (PIK) interest income | 2 | 3 | 8 | 0 | 0 | |
| Total investment income | 96 | 100 | 113 | 79 | 60 | |
| Interest expense | 33 | 32 | 29 | 19 | 12 | |
| Base management fee (Note 3) | 12 | 12 | 13 | 11 | 8 | |
| Performance based incentive fee (Note 3) | 0 | 295,000 | 3 | 8 | 7 | |
| Administrative fee (Note 3) | 2 | 2 | 2 | 2 | 1 | |
| Professional fees | 3 | 2 | 2 | 2 | 2 | |
| General and administrative | 2 | 2 | 2 | 1 | 2 | |
| Total expenses | 51 | 51 | 51 | 42 | 31 | |
| Net investment income before excise tax | 45 | 49 | 63 | 37 | 29 | |
| Provision for excise tax | 1 | 1 | 1 | 715,000 | 401,000 | |
| Net investment income | 44 | 48 | 61 | 36 | 28 | |
| Net realized gain (loss) on investments | −55 | −35 | −30 | −9 | −3 | |
| Net realized loss on extinguishment of debt | −3 | 0 | −151,000 | 0 | −395,000 | |
| Net realized loss | −58 | −35 | −30 | — | — | |
| Net unrealized appreciation (depreciation) on investments | 11 | −19 | −49 | −6 | 3 | |
| Net realized and unrealized loss | −47 | −53 | −79 | −15 | −438,000 | |
| Net decrease in net assets resulting from operations | −3 | −6 | −17 | 21 | 28 | |
| Net investment income per common share - basic (in dollars per share) | 1.05 | 1.32 | 1.98 | 1.46 | 1.41 | |
| Net investment income per common share - diluted (in dollars per share) | 1.05 | 1.32 | 1.98 | 1.46 | — | |
| Net decrease in net assets resulting from operations per common share - basic (in dollars per share) | −0.06 | −0.16 | −0.56 | 0.86 | 1.39 | |
| Net decrease in net assets resulting from operations per common share - diluted (1) (in dollars per share) | −0.06 | −0.16 | −0.56 | 0.86 | — | |
| Weighted average shares outstanding - basic (in shares) | 42 | 36 | 31 | 25 | — | |
| Weighted average shares outstanding - diluted (in shares) | 42 | 36 | 31 | 25 | — | |
| Distributions declared per share (in dollars per share) | 1.32 | 1.37 | 1.37 | 1.28 | 1.25 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Investments at fair value | 647 | 698 | 709 | 720 | 458 | |
| Cash | 106 | 70 | 47 | 21 | 38 | |
| Investments in money market funds | 35 | 27 | 26 | 7 | 8 | |
| Restricted investments in money market funds | 2 | 3 | 3 | 3 | 1 | |
| Interest receivable | 12 | 17 | 14 | 14 | 6 | |
| Other assets | 9 | 7 | 4 | 3 | 2 | |
| Total assets | 811 | 822 | 802 | 767 | 514 | |
| Borrowings (Note 7) | 473 | 468 | 462 | 434 | 258 | |
| Distributions payable | 15 | 13 | 11 | 9 | — | |
| Base management fee payable (Note 3) | 975,000 | 1 | 1 | 1 | 706,000 | |
| Other accrued expenses | 4 | 4 | 4 | 3 | 2 | |
| Total liabilities | 493 | 486 | 478 | 448 | 269 | |
| Commitments and contingencies (Notes 3 and 8) | — | — | — | — | — | |
| Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, par value $0.001 per share, 100,000,000 shares authorized, 45,781,280 and 40,043,312 shares issued and 45,613,815 and 39,875,847 shares outstanding as of December 31, 2025 and 2024, respectively | 51,000 | 44,000 | 36,000 | 29,000 | 22,000 | |
| Paid-in capital in excess of par | 559 | 518 | 451 | 386 | 301 | |
| Distributable loss | −241 | −182 | −127 | −68 | −56 | |
| Total net assets | 319 | 336 | 324 | 318 | 245 | |
| Total liabilities and net assets | 811 | 822 | 802 | 767 | 514 | |
| Net asset value per common share (in dollars per share) | 6.98 | 8.43 | 9.71 | 11.47 | 11.56 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Amortization of debt issuance costs | 3 | 2 | 2 | 2 | 1 | |
| Net realized loss on investments | 55 | 35 | 30 | 9 | 3 | |
| Purchase of investments | −224 | −182 | −219 | −422 | −344 | |
| Principal payments received on investments | 234 | 146 | 152 | 96 | 188 | |
| Proceeds from sale of investments | 6 | 302,000 | 11 | 50 | 53 | |
| Equity received in settlement of interest and fee income | −5 | 0 | −89,000 | — | — | |
| Warrants received in settlement of fee income | −71,000 | −359,000 | −80,000 | 0 | 0 | |
| Accrued interest converted to common stock | 137,000 | 0 | 0 | — | — | |
| Decrease (increase) in interest receivable | 687,000 | −922,000 | 2 | −3 | −173,000 | |
| Decrease (increase) in end-of-term payments | 4 | −2 | −2 | −4 | −2 | |
| Decrease in unearned income | −3 | −3 | −4 | −394,000 | −1 | |
| Increase in other assets | −1 | −246,000 | −650,000 | −156,000 | −394,000 | |
| Increase (decrease) in other accrued expenses | 5,000 | −535,000 | 1 | 758,000 | 509,000 | |
| Decrease in base management fee payable | −70,000 | −7,000 | −13,000 | 359,000 | 143,000 | |
| Decrease in incentive fee payable | 0 | 0 | −1 | −623,000 | 1 | |
| Net cash provided by (used in) operating activities | 57 | 4 | −5 | −246 | −76 | |
| Proceeds from issuance of 2028 Notes | 58 | 0 | 0 | — | — | |
| Proceeds from issuance of common stock, net of offering costs | 14 | 66 | 65 | 85 | 30 | |
| Advances on Credit Facilities | 15 | 75 | 104 | 199 | 127 | |
| Repayment of Credit Facilities | 0 | −70 | −35 | −150 | −45 | |
| Debt issuance costs | −7 | −5 | −735,000 | −4 | −3 | |
| Distributions paid | −53 | −46 | −41 | −30 | −25 | |
| Net cash (used in) provided by financing activities | −15 | 21 | 51 | 229 | 76 | |
| Net increase in cash, cash equivalents and restricted cash | 42 | 25 | 45 | −17 | −477,000 | |
| Cash paid for interest | 30 | 30 | 27 | 17 | 11 | |
| Refinanced debt investment balances | 79 | 28 | 33 | 31 | 0 | |
| Warrant and equity investments received and recorded as unearned income | 2 | 2 | 3 | 6 | 3 | |
| Debt converted to common stock | 26 | 0 | 0 | — | — | |
| End-of-term payments receivable | 10 | 14 | 12 | 10 | 5 | |
| Non-cash income | 14 | 12 | 17 | 6 | 5 |